Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 53

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 53
---
 affirmative vote of a majority of the votes cast is required to approve this proposal, excluding abstentions and broker non-votes. The board of directors recommends that stockholders vote “FOR” approval of Amendment No. 3.

<div align='center'>30</div>

RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Proposal 5) Our audit committee has selected the firm of KPMG LLP to be the Company’s independent registered public accounting firm to conduct an audit of the Company’s consolidated financial statements for the year ending December 31, 2025 and the Company’s internal control over financial reporting. A representative of that firm is expected to be present at the Annual Meeting to respond to appropriate questions and will be given an opportunity to make a statement if he or she so desires. This appointment is being submitted for ratification at the meeting. If not ratified, the audit committee will reconsider this appointment, although the audit committee will not be required to appoint different independent auditors. KPMG LLP has served as our independent auditors since 2002. Audit and Other Fees The following table shows fees for professional services rendered by KPMG LLP for the years ended December 31, 2024 and December 31, 2023:

|                    | Fees |   |      2024 |     |   |      2023 |
|:-------------------|:-----|:--|----------:|:----|:--|----------:|
| Audit fees         |      | $ | 2,879,399 |     | $ | 2,319,027 |
| Audit-related fees |      |   |         - |     |   |         - |
| Tax fees           |      |   | 1,024,698 |     |   | 1,037,421 |
| All other fees     |      |   |    16,960 |     |   |    11,060 |
| Total              |      |   | 3,921,057 |     |   | 3,367,508 |

Audit fees are fees for the integrated audit of our 2024 and 2023 consolidated financial statements and effectiveness of internal control over financial reporting included in our Annual Reports on Form 10-K, reviews of our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q and other services that are provided in connection with statutory and regulatory filings, such as consents. Tax fees are fees for international, federal